Morepen Laboratories Q2 Results
- BSE: 500288
- NSE: MOREPENLAB
- ISIN: INE083A01026
- Sector: Biotechnology & Drugs
BSE
47.27
-2.10 (-4.25%)
-2.10 (-4.25%)Volume7.07 L
Updated: Thu 11 Jun, 2026 | 15:40:01
NSE
47.29-2.08 (-4.21%)
-2.08 (-4.21%)Volume11.28 M
Updated: Thu 11 Jun, 2026 | 15:42:41
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Morepen Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 366.34 | 410.09 | -10.67% | 395.51 | -7.38% |
| Depreciation/ Amortization | 11.28 | 9.03 | 24.99% | 1.86 | 507.77% |
| Operating Income | 45.24 | 15.15 | 198.69% | 42.21 | 7.17% |
| Net Income | 40.87 | 10.75 | 280.29% | 34.85 | 17.29% |
| Other Operating Expenses Total | 29.41 | 36.32 | -19.03% | 31.50 | -6.63% |
| Net Income Before Taxes | 45.69 | 15.52 | 194.49% | 46.02 | -0.71% |
| Total Revenue | 411.58 | 425.24 | -3.21% | 437.73 | -5.97% |
| Selling/ General/ Admin Expenses Total | 76.11 | 91.82 | -17.11% | 81.76 | -6.91% |
| Diluted Normalized EPS | 0.32 | 0.20 | 62.18% | 0.65 | -50.10% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.